Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
Travere Therapeutics Issues New Convertible Notes to Refinance Debt
H.C. Wainwright Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $57
Express News | Travere Therapeutics Inc - Offers $475 Mln of 0.50% Convertible Senior Notes Due 2032 - SEC Filing
J.P. Morgan Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $54
Travere Therapeutics Prices Upsized $475 Million Debt Offering
Travere Therapeutics Insider Sold Shares Worth $360,000, According to a Recent SEC Filing